Advertisement

Topics

Alexion,Sema4 Partner In Rare Disease Diagnostics And Systems Biology

06:56 EDT 10 Aug 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals Inc. (ALXN) and Sema4 announced a strategic partnership to leverage their shared experience in data science and systems biology to accelerate rare di...

Original Article: Alexion,Sema4 Partner In Rare Disease Diagnostics And Systems Biology

NEXT ARTICLE

More From BioPortfolio on "Alexion,Sema4 Partner In Rare Disease Diagnostics And Systems Biology"

Quick Search
Advertisement
 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...